Ace Therapeutics customizes extensive disease models to meet specific research needs.
At Ace Therapeutics, our goal is to advance research and accelerate new drug development for gastrointestinal (GI) and liver diseases. To achieve this, we have developed extensive expertise in customizing relevant preclinical models. A key strength is our ability to tailor these diverse model platforms to the specific needs of researchers and provide associated testing services. Whether you require organoids, genetically engineered animal models, or advanced microfluidic systems, we have the capabilities to support you.
Ace Therapeutic offers a full range of customizable esophageal disease modeling services. Using organoids and animal models, we can recreate esophageal tissue damage, motility dysfunction, bacterial overgrowth, and inflammatory responses associated with conditions like GERD and Barrett's esophagus. Our model systems can provide personalized insights and preclinical platforms for the development of novel diagnostics and therapeutics.
At Ace Therapeutic, we have extensive capabilities for customizing preclinical gastrointestinal disease models. Through approaches like CRISPR genome editing, microbiome engineering and surgical techniques in rodents, we can replicate multiple disease factors such as genetic mutations, epithelial damage and microbial dysbiosis. We offer tailored solutions for disease research and drug development.
The Hepatology Research Division at Ace Therapeutic has created numerous preclinical liver disease models that are ideal for compound screening and in-depth molecular efficacy analysis. Our mission is to offer you comprehensive pharmacological data on your candidate compounds of interest, streamlining the drug development process. Moreover, we can establish correlations between the study of specific biomarkers and relevant parameters through histology and/or ELISA.
Ace Therapeutic specializes in mouse models comorbid with primary sclerosing cholangitis and inflammatory bowel disease. Through genomic engineering, our models investigate how colitis impacts bile acid metabolism and liver cholestasis at molecular levels. Metabolomic analyses of bile, cholesterol, fat and fat-soluble vitamins allow assessment of candidate compounds' ability to treat biliary dysfunction and evaluate pathological linkages between the gut and liver.
Ace Therapeutic specializes in customizing disease models to facilitate research on various aspects of pancreatic diseases, including protein misfolding, endoplasmic reticulum stress, autophagy abnormalities, and inflammatory signaling pathway abnormalities. With our expertise, we can support developing drugs that target the underlying causes, manage pain, preserve pancreatic function, and address associated comorbidities.
Discuss your specific research needs
Confirm customized quote
Draft agreement and detailed contract
Develop models and conduct tests
Deliver results
At Ace Therapeutic, our customized approach supports a wide range of research applications from target discovery to predictive efficacy testing. If you would like to partner with us to create breakthroughs in understanding and treating complex gastrointestinal and liver diseases, please feel free to contact us.
Our products and services are for research use only and can not be used for diagnostic or other purposes.